Search results for "SART"

showing 10 items of 212 documents

Carcinoma of the tongue and bulbar-onset amyotrophic lateral sclerosis: unusual differential diagnosis.

2007

We present a 72-year-old woman with progressive dysphagia, dysarthria and tongue palsy who was initially diagnosed with bulbar-onset amyotrophic lateral sclerosis (ALS). However, the absence of atrophy or fasciculations in the tongue, as in other voluntary muscles, and the lack of reproducible neurophysiological evidence of denervation, prompted a revision of the diagnostic work-up, which eventually led to the discovery of a carcinoma of the tongue. This case report describes a relatively rare type of oropharyngeal carcinoma that, in its early stage, resembled a bulbar-onset ALS. This differential diagnosis is unusual, and it was fostered by the persistent lack of atrophy of the tongue and …

Pathologymedicine.medical_specialtyDermatologyDiagnosis DifferentialAtrophyTongueAphasiaHumansParalysisMedicineAmyotrophic lateral sclerosisAgedDenervationPalsyElectromyographybusiness.industryDysarthriaAmyotrophic Lateral SclerosisGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingDysphagiaTongue NeoplasmsAmotrophic lateral Sclerosis Motor Neuron DeseasePsychiatry and Mental healthmedicine.anatomical_structureOropharyngeal CarcinomaCarcinoma Squamous CellFemaleNeurology (clinical)Differential diagnosismedicine.symptombusiness
researchProduct

Isolated dysarthria due to extracerebellar lacunar stroke: a central monoparesis of the tongue

1999

OBJECTIVES—The pathophysiology of dysarthria can preferentially be studied in patients with the rare lacunar stroke syndrome of "isolated dysarthria". METHODS— A single study was carried out on seven consecutive patients with sudden onset of isolated dysarthria due to single ischaemic lesion. The localisation of the lesion was identified using MRI. The corticolingual, cortico-orofacial, and corticospinal tract functions were investigated using transcranial magnetic stimulation. Corticopontocerebellar tract function was assessed using 99mTc hexamethylpropylene amine oxime-single photon emission computerised tomography (HMPAO-SPECT) in six patients. Sensory functions were evaluated clinically…

Pathologymedicine.medical_specialtyLacunar strokeInternal capsulebusiness.industryCerebral infarctionmedicine.diseasenervous system diseasesLesionPsychiatry and Mental healthDysarthriaSomatosensory evoked potentialCorticospinal tractmedicineSurgeryNeurology (clinical)medicine.symptombusinessStrokeJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Chapter 35 Transcranial magnetic stimulation in brainstem lesions and lesions of the cranial nerves

2003

Publisher Summary This chapter focuses on transcranial magnetic stimulation (TMS) applications in brainstem pathology and on the description of TMS techniques for the evaluation of motor cranial nerve function, which is an essential measure in the diagnostic workup of brain-stern lesions. Applications of TMS to the cranial nerve innervated muscles have been the objective of numerous investigations, ranging from basic neuroanatomic studies to determine the central course of corticonuclear projections to clinical applications carried out to determine the location of lesions, investigate the pathophysiology of ischemic dysarthria, detect clinically silent lesions in multiple sclerosis, obtain …

Pathologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCranial nervesAnatomyMotor neuronmedicine.diseaseFacial nerveFacial paralysisTranscranial magnetic stimulationDysarthriamedicine.anatomical_structureCranial Nerve InjuryHypoglossal Nerve Diseasesmedicinemedicine.symptombusiness
researchProduct

Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelialcell interactionsin vivo

2001

Chronic inhibition of nitric oxide synthase (NOS) provokes a hypertensive state which has been shown to be angiotensin II (Ang-II) dependent. In addition to raising blood pressure, NOS inhibition also causes leukocyte adhesion. The present study was designed to define the role of Ang-II in hypertension and in the leukocyte-endothelial cell interactions induced by acute NOS or cyclo-oxygenase (COX) inhibition using intravital microscopy within the rat mesenteric microcirculation. While pretreatment with an Ang-II AT1 receptor antagonist (losartan) reversed the prompt increase in mean arterial blood pressure (MABP) caused by indomethacin, it had no effect on the increase evoked by systemic L-…

Pharmacologymedicine.medical_specialtyAngiotensin II receptor type 1EndotheliumbiologyLeukocyte RollingProstacyclinAngiotensin IINitric oxideNitric oxide synthasechemistry.chemical_compoundLosartanmedicine.anatomical_structureEndocrinologychemistryInternal medicinecardiovascular systemmedicinebiology.proteinhormones hormone substitutes and hormone antagonistsmedicine.drugBritish Journal of Pharmacology
researchProduct

Facebook’s Emotional Contagion Experiment as a Challenge to Research Ethics

2016

This article analyzes the ethical discussion focusing on the Facebook emotional contagion experiment published by the <em>Proceedings of the National Academy of Sciences</em> in 2014. The massive-scale experiment manipulated the News Feeds of a large amount of Facebook users and was successful in proving that emotional contagion happens also in online environments. However, the experiment caused ethical concerns within and outside academia mainly for two intertwined reasons, the first revolving around the idea of research as manipulation, and the second focusing on the problematic definition of informed consent. The article concurs with recent research that the era of social med…

PrivatsphäreFacebookresearch ethicsuser dataEmotional contagionddc:070Sociology & anthropologylcsh:Communication. Mass mediaForschungsarten der Sozialforschung0508 media and communicationsbig dataSoziale MedienInformed consentyksityisyysUtilitarianismData Protection Act 1998Sociologyta518emotionalitySozialwissenschaften Soziologiescience ethicsCommunication05 social sciencesinformed consentmethodologyMethodologie06 humanities and the artsPublic relationsWissenschaftsethiklcsh:P87-96Deontological ethicsResearch Designtutkimusetiikkaddc:300manipulaatio (psykologia)ddc:301Sociology of Science Sociology of Technology Research on Science and TechnologyWissenschaftssoziologie Wissenschaftsforschung Technikforschung TechniksoziologieSocial psychologyBig data; emotional contagion; informed consent; manipulation; research ethics; user dataCyberpsychologysocial mediasosiaalinen media050801 communication & media studiesemotional contagion0603 philosophy ethics and religionprivacyBig dataInteractive electronic Mediatietoon perustuva suostumusEmotionalitätSocial mediaDatengewinnungSocial sciences sociology anthropologyinteraktive elektronische MedienNews media journalism publishingdata protectionResearch ethicsForschungresearchComputingMilieux_THECOMPUTINGPROFESSIONbusiness.industrymetodologiaDatenschutzdata captureSoziologie AnthropologiemanipulationPublizistische Medien JournalismusVerlagswesen060301 applied ethicsbusinessMedia and Communication
researchProduct

The Tense-Aspect system between ontogeny and phylogeny: Evidence from the Proto-Indo-European “Injunctive”

2006

This paper examines early inflectional morphology related to the tense-aspect system of Pre-Indo-European by establishing a correlation between ontogeny and phylogeny in language acquisition and development. It will be argued that historical linguistics can shed light on the long-standing debate over the emergence of tense-aspect morphology. More specifically, the so-called Injunctive forms, which are assumed to be the most ancient verbal inflected items tracing back to the Pre-Indo-European language (see, among others, Lehmann 2002), permit us to infer that the initial grammar of the Proto-language was lacking tense morphology. In other words, the residual category of the Injunctive, which…

Proto-Indo-Europeanlanguage acquisitionSanskritAktionsarttense-aspect morphologyGreekSettore L-LIN/01 - Glottologia E Linguistica
researchProduct

Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)

2012

In the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial, telmisartan (T; 80 mg daily) and ramipril (R; 10 mg daily) caused similar clinic blood pressure (BP) reductions, with a similar incidence of cardiovascular and renal events. The R+T combination lowered clinic BP somewhat more with no further cardiovascular or renal protection. The aim of this substudy was to see whether these clinic BP changes reflected the changes of 24-hour BP, a BP with a better prognostic value. In 422 patients in whom 24-hour BP monitoring was performed either before or after 6 to 24 months of treatment, demographic and clinical characteristics were similar in the 3 treated groups.…

RamiprilMalemedicine.medical_specialtyAmbulatory blood pressureDiastoleAngiotensin-Converting Enzyme InhibitorsBlood PressureBenzoateslaw.inventionRandomized controlled trialRamiprillawInternal medicineInternal MedicinemedicineHumansLongitudinal StudiesTelmisartanAntihypertensive AgentsAgedbusiness.industryambulatory blood pressure antihypertensive treatment high cardiovascular risk angiotensin-converting enzyme inhibitors angiotensin receptor blockersMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring AmbulatoryMiddle AgedEndocrinologyBlood pressureTreatment OutcomeTarget drugAmbulatoryHypertensionCardiologyBenzimidazolesDrug Therapy CombinationFemaleTelmisartanbusinessmedicine.drug
researchProduct

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpo…

2009

Hypertension guidelines advise aggressive blood pressure (BP) lowering in patients with diabetes or high cardiovascular risk, but supporting evidence is limited. We analysed the impact of BP on cardiovascular events in well treated high-risk patients enrolled in a large clinical trial (Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).Twenty-five thousand five hundred and eighty-eight patients with atherosclerotic disease or diabetes with organ damage, tolerant to angiotensin-converting enzyme inhibitors, were randomized to ramipril, telmisartan or both. We related the primary composite outcome and its components to: baseline SBP; SBP changes from baseline to…

RamiprilMalemedicine.medical_specialtyPhysiologyAngiotensin-Converting Enzyme InhibitorsBlood PressureBenzoateslaw.inventionRandomized controlled trialDouble-Blind MethodRamiprillawInternal medicineInternal MedicinemedicineHumansTelmisartanRisk factorAntihypertensive AgentsAgedVascular diseasebusiness.industryMiddle Agedmedicine.diseasePrognosisAngiotensin IISurgeryClinical trialBlood pressureTreatment OutcomeHypertensionCardiologyBenzimidazolesFemaleTelmisartanCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of hypertension
researchProduct

Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor bl…

2006

BACKGROUND.: In this study the effects of 24 weeks losartan and ramipril treatment, both alone and in combination, on blood pressure and left ventricular mass (LVM) and function, have been evaluated in hypertensives. METHODS.: 57 hypertensives with stage 1 and 2 essential hypertension were included. After 4 weeks run in, a randomized double-blind, 3 arm, double dummy, independent trial was used. All patients were randomly allocated to 3 treatment arms consisting of losartan (50 mg/daily), ramipril (5 mg/daily), and combined (losartan 50 mg/ramipril 5 mg/daily) for 24 weeks. LVM, LVM/h(2.7) and other echocardiographic measurements, BUN, creatinine and clearance and potassium were determined …

Ramiprillcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyLeft ventricular geometry and functionAngiotensin II receptor blockersLeft ventricular hypertrophyEssential hypertensionArticlechemistry.chemical_compoundInternal medicinemedicineAce-inhibitors Angiotensin II receptor blockers Left ventricular geometry and functioncardiovascular diseasesAce-inhibitorsCreatininebusiness.industrymedicine.diseaseAngiotensin IILosartanBlood pressurechemistrylcsh:RC666-701ACE inhibitorCardiologyCardiology and Cardiovascular Medicinebusinessmedicine.drugHeart International
researchProduct

Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.

2020

AIMS There is conflicting evidence on whether in treated hypertensive patients the risk of renal outcomes is associated with visit-to-visit SBP variability. Furthermore, limited evidence is available on how important is SBP variability for prediction of renal outcomes compared with on-treatment mean SBP. We addressed these issues in 28 790 participants of the Ongoing Treatment Alone and in combination with Ramipril Global End point Trial and Telmisartan Randomized Assessment Study in ace iNtolerant Subjects with Cardiovascular Disease trials. METHODS AND RESULTS SBP variability was expressed as the coefficient of variation of the mean with which it showed no relationship. SBP variability an…

Ramiprilmedicine.medical_specialtyPhysiologyBlood Pressure030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineInternal MedicineMedicineHumanscardiovascular diseases030212 general & internal medicineAntihypertensive AgentsCreatininebusiness.industryIncidence (epidemiology)Confoundingmedicine.diseaseBlood pressureMean blood pressurechemistryCreatinineHypertensionCardiologyKidney Failure ChronicMicroalbuminuriaTelmisartanCardiology and Cardiovascular Medicinebusinesscirculatory and respiratory physiologymedicine.drugJournal of hypertension
researchProduct